» Articles » PMID: 17099894

Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis Mutant Superoxide Dismutase-1 Transgenic Mice: Mechanisms of Mitochondriopathy and Cell Death

Overview
Journal J Comp Neurol
Specialty Neurology
Date 2006 Nov 14
PMID 17099894
Citations 134
Authors
Affiliations
Soon will be listed here.
Abstract

The mechanisms of human mutant superoxide dismutase-1 (mSOD1) toxicity to motor neurons (MNs) are unresolved. We show that MNs in G93A-mSOD1 transgenic mice undergo slow degeneration lacking similarity to apoptosis structurally and biochemically. It is characterized by somal and mitochondrial swelling and formation of DNA single-strand breaks prior to double-strand breaks occurring in nuclear and mitochondrial DNA. p53 and p73 are activated in degenerating MNs, but without nuclear import. The MN death is independent of activation of caspases-1, -3, and -8 or apoptosis-inducing factor within MNs, with a blockade of apoptosis possibly mediated by Aven up-regulation. MN swelling is associated with compromised Na,K-ATPase activity and aggregation. mSOD1 mouse MNs accumulate mitochondria from the axon terminals and generate higher levels of superoxide, nitric oxide, and peroxynitrite than MNs in control mice. Nitrated and aggregated cytochrome c oxidase subunit-I and alpha-synuclein as well as nitrated SOD2 accumulate in mSOD1 mouse spinal cord. Mitochondria in mSOD1 mouse MNs accumulate NADPH diaphorase and inducible nitric oxide synthase (iNOS)-like immunoreactivity, and iNOS gene deletion extends significantly the life span of G93A-mSOD1 mice. Prior to MN loss, spinal interneurons degenerate. These results identify novel mechanisms for mitochondriopathy and MN degeneration in amyotrophic lateral sclerosis (ALS) mice involving blockade of apoptosis, accumulation of MN mitochondria with enhanced toxic potential from distal terminals, NOS localization in MN mitochondria and peroxynitrite damage, and early degeneration of alpha-synuclein(+) interneurons. The data support roles for oxidative stress, protein nitration and aggregation, and excitotoxicity as participants in the process of MN degeneration caused by mSOD1.

Citing Articles

Insights into therapeutic approaches for the treatment of neurodegenerative diseases targeting metabolic syndrome.

Thapa K, Khan H, Chahuan S, Dhankhar S, Kaur A, Garg N Mol Biol Rep. 2025; 52(1):260.

PMID: 39982557 DOI: 10.1007/s11033-025-10346-0.


Oxidative/Nitrosative Stress, Apoptosis, and Redox Signaling: Key Players in Neurodegenerative Diseases.

Uremis N, Uremis M J Biochem Mol Toxicol. 2025; 39(1):e70133.

PMID: 39799559 PMC: 11725306. DOI: 10.1002/jbt.70133.


Natural Products and Their Neuroprotective Effects in Degenerative Brain Diseases: A Comprehensive Review.

Lim D, Lee J, Lee C, Kim Y Int J Mol Sci. 2024; 25(20).

PMID: 39457003 PMC: 11508681. DOI: 10.3390/ijms252011223.


Nuclear Localization of Human SOD1 in Motor Neurons in Mouse Model and Patient Amyotrophic Lateral Sclerosis: Possible Links to Cholinergic Phenotype, NADPH Oxidase, Oxidative Stress, and DNA Damage.

Martin L, Koh S, Price A, Park D, Kim B Int J Mol Sci. 2024; 25(16).

PMID: 39201793 PMC: 11354607. DOI: 10.3390/ijms25169106.


Dysregulation of persistent inward and outward currents in spinal motoneurons of symptomatic SOD1-G93A mice.

Deutsch A, Elbasiouny S J Physiol. 2024; 602(15):3715-3736.

PMID: 38924530 PMC: 11293966. DOI: 10.1113/JP286032.